Unlocking the value of life-improving medicines
Boston Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing highly engineered therapies to transform the lives of patients who fight serious liver diseases.
Innovative collaborations and evidence-based decision making are core to our ways of working
We have partnered with biotechnology and pharmaceutical companies to acquire innovative drug candidates. We employ unencumbered decision making and advance only those programs that meet our stringent development hurdles.
A Path to Value for Our Partners and Patients
We have established partnerships with the world’s leading biotechnology and pharmaceutical companies. We continue to seek new ways to leverage our model and create a path to value for our partners and patients across serious liver diseases.
Recent News
11/15/2024
10/16/2024
06/06/2024
Boston Pharmaceuticals Appoints Dr. Margaret Koziel as New Chief Medical Officer
06/05/2024
05/23/2024